Cargando…

Risk of Death from Prostate Cancer with and without Definitive Local Therapy when Gleason Pattern 5 is Present: A Surveillance, Epidemiology, and End Results Analysis

Purpose The purpose is to evaluate the patterns of care and comparative effectiveness for cause-specific and overall survival of definitive local treatments versus conservatively managed men with a primary or secondary Gleason pattern of 5. Methods and materials Patients diagnosed from 2004 to 2012...

Descripción completa

Detalles Bibliográficos
Autores principales:	Frandsen, Jonathan, Orton, Andrew, Shrieve, Dennis, Tward, Jonathan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2017
Materias:	Radiation Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5590810/ https://www.ncbi.nlm.nih.gov/pubmed/28929037 http://dx.doi.org/10.7759/cureus.1453

Ejemplares similares

Individualized margins for prostate patients using a wireless localization and tracking system
por: Rassiah‐Szegedi, Prema, et al.
Publicado: (2011)

Stereotactic Body Radiotherapy for Hepatocellular Carcinoma Resulting in a Durable Relapse-Free Survival: A Case Report
por: Francis, Samual, et al.
Publicado: (2016)

Factors influencing prostate cancer patterns of care: An analysis of treatment variation using the SEER database
por: Burt, Lindsay M., et al.
Publicado: (2018)

Demographics, stage distribution, and relative roles of surgery and radiotherapy on survival of persons with primary prostate sarcomas
por: Tward, Jonathan D., et al.
Publicado: (2018)

Patterns of Care and Outcomes of Adjuvant Radiotherapy for Meningiomas: A Surveillance, Epidemiology, and End Results and Medicare Linked Analysis
por: Amsbaugh, Mark, et al.
Publicado: (2016)

Diet quality and Gleason grade progression among localised prostate cancer patients on active surveillance
por: Gregg, Justin R., et al.
Publicado: (2019)

Calculation of delivered composite dose from Calypso tracking data for prostate cancer: And subsequent evaluation of reasonable treatment interruption tolerance limits
por: Zhao, Hui, et al.
Publicado: (2019)

Prostate Cancer in Patients with Metabolic Syndrome Is Associated with Low Grade Gleason Score When Diagnosed on Biopsy
por: Jeon, Kyoung Pil, et al.
Publicado: (2012)

Biochemical Recurrence in Gleason Score 7 Prostate Cancer in Korean Men: Significance of the Primary Gleason Grade
por: Ro, Yun Kwan, et al.
Publicado: (2012)

The impact of the 2005 International Society of Urological Pathology Gleason grading consensus on active surveillance for prostate cancer
por: Ramakrishnan, Venkat M., et al.
Publicado: (2017)

Influence of Active Surveillance on Gleason Score Upgrade and Prognosis in Low- and Favorable Intermediate-Risk Prostate Cancer
por: Hu, Xuanhan, et al.
Publicado: (2022)

Association between DNA methylation of HSPB1 and death in low Gleason score prostate cancer
por: Vasiljević, N, et al.
Publicado: (2013)

The gut microbiota associated with high‐Gleason prostate cancer
por: Matsushita, Makoto, et al.
Publicado: (2021)

Gleason 6 prostate cancer: That which cannot be named
por: Burke, Harry B.
Publicado: (2022)

Prediction of pathologic upgrading in Gleason score 3+4 prostate cancer: Who is a candidate for active surveillance?
por: Pham, Duc Minh, et al.
Publicado: (2020)

Personalised biopsy schedules based on risk of Gleason upgrading for patients with low‐risk prostate cancer on active surveillance
por: Tomer, Anirudh, et al.
Publicado: (2020)

Epigenetic signature of Gleason score and prostate cancer recurrence after radical prostatectomy
por: Geybels, Milan S., et al.
Publicado: (2016)

Differences in survival of prostate cancer Gleason 8–10 disease and the establishment of a new Gleason survival grading system
por: Zhou, Yuan, et al.
Publicado: (2020)

Association Between a 22-feature Genomic Classifier and Biopsy Gleason Upgrade During Active Surveillance for Prostate Cancer
por: Press, Benjamin H., et al.
Publicado: (2022)

Evaluation of fluence‐smoothing feature for three IMRT planning systems
por: Anker, Christopher J., et al.
Publicado: (2010)

The use of a thin guide‐wire for urethral definition in prostate SBRT treatments with Cyberknife
por: Sevillano, David, et al.
Publicado: (2023)

Validation of the WHO 2016 new Gleason score of prostatic carcinoma
por: Rao, Vishal, et al.
Publicado: (2018)

Multimodal Radiomic Features for the Predicting Gleason Score of Prostate Cancer
por: Chaddad, Ahmad, et al.
Publicado: (2018)

Beyond the Gleason score: the prognostic significance of prostate cancer subtypes
por: Flood, Trevor A., et al.
Publicado: (2018)

Clinical significance of subtypes of Gleason pattern 4 prostate cancer
por: Hassan, Oudai, et al.
Publicado: (2018)

Expression of stromal elements of prostatic adenocarcinoma in different gleason scores
por: Osorio, Clarice Fraga Esteves Maciel, et al.
Publicado: (2019)

The Ability of Prostate Health Index (PHI) to Predict Gleason Score in Patients With Prostate Cancer and Discriminate Patients Between Gleason Score 6 and Gleason Score Higher Than 6—A Study on 320 Patients After Radical Prostatectomy
por: Dolejsova, Olga, et al.
Publicado: (2018)

Metastases with definitive pathological diagnosis but no detectable primary tumor: A surveillance epidemiology and end results‐based study
por: Tao, Lianyuan, et al.
Publicado: (2019)

The values of neutrophil-lymphocyte ratio and/or prostate-specific antigen in discriminating real Gleason score ≥ 7 prostate cancer from group of biopsy-based Gleason score ≤ 6
por: Wang, Hanfeng, et al.
Publicado: (2017)

Correlation of Gleason Scores with Diffusion-Weighted Imaging Findings of Prostate Cancer
por: Nagarajan, Rajakumar, et al.
Publicado: (2012)

Correlation of concentrations of selected trace elements with Gleason grade of prostate tissues
por: Banas, A., et al.
Publicado: (2010)

Predicting Gleason Score of Prostate Cancer Patients Using Radiomic Analysis
por: Chaddad, Ahmad, et al.
Publicado: (2018)

Pelvic nodal radiotherapy in Gleason grade group 5 prostate cancer
por: Cook, Kiri, et al.
Publicado: (2020)

MYC DNA Methylation in Prostate Tumor Tissue is Associated with Gleason Score
por: Barry, Kathryn Hughes, et al.
Publicado: (2020)

Favorable intermediate risk prostate cancer with biopsy Gleason score of 6
por: Oh, Jong Jin, et al.
Publicado: (2021)

Artificial intelligence for diagnosis and Gleason grading of prostate cancer: the PANDA challenge
por: Bulten, Wouter, et al.
Publicado: (2022)

Lectures on Gleason parts
por: Bear, Herbert S
Publicado: (1970)

Dr. S. O. Gleason
Publicado: (1899)

Self‐expanding stent effects on radiation dosimetry in esophageal cancer
por: Francis, Samual R., et al.
Publicado: (2013)

Spatial and dosimetric evaluation of residual distortions of prostate and seminal vesicle bed after image‐guided definitive and postoperative radiotherapy of prostate cancer with endorectal balloon
por: Levegrün, Sabine, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cgie1upcl9bg1aserh11pp554j